13F

Stock

Processa Pharmaceuticals, Inc.

PCSA · held by 10 managers

Reported value

$448.5K

Holders

10

+2 new · −3 exited

Holders’ est. mark

−$11.1K

Price effect on 6 books still in the name

Largest holder

$178.6K

Connective Capital Management, LLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Connective Capital Management, LLC70.7K$178.6KNew
Stonepine Capital Management, LLC55K$138.9K−$4.37KAdded$103.4K
GEODE CAPITAL MANAGEMENT, LLC24.9K$62.8K−$5.52KAdded$18.6K
VANGUARD CAPITAL MANAGEMENT LLC12.7K$32.1KHeld
VANGUARD FIDUCIARY TRUST CO10.9K$27.4KHeld
UBS Group AG2.53K$6.39K−$898Cut−$30K
Tower Research Capital LLC (TRC)918$2.32K−$326Cut−$1.69K
CITIGROUP INC14$35New
JONES FINANCIAL COMPANIES LLLP7$17−$3Cut−$3
WELLS FARGO & COMPANY/MN6$15−$2Cut−$2

Who left

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.